Valsartan in the Treatment of Heart Attack Survivors

  title={Valsartan in the Treatment of Heart Attack Survivors},
  author={Bodh I. Jugdutt},
  journal={Vascular Health and Risk Management},
  pages={125 - 138}
Survivors of myocardial infarction (MI) are at high risk of disability and death. This is due to infarct-related complications such as heart failure, cardiac remodeling with progressive ventricular dilation, dysfunction, and hypertrophy, and arrhythmias including ventricular and atrial fibrillation. Angiotensin (Ang) II, the major effector molecule of the renin-angiotensin-aldosterone system (RAAS) is a major contributor to these complications. RAAS inhibition, with angiotensin-converting… CONTINUE READING


Publications citing this paper.
Showing 1-8 of 8 extracted citations

Valsartan Upregulates Kir2.1 in Rats Suffering from Myocardial Infarction via Casein Kinase 2

Cardiovascular Drugs and Therapy • 2015
View 1 Excerpt
Highly Influenced

High-affinity interaction of sartans with H+/peptide transporters.

Drug metabolism and disposition: the biological fate of chemicals • 2009
View 1 Excerpt


Publications referenced by this paper.
Showing 1-10 of 127 references

Limitation of excessive

F Zannad, F Alla, B Dousset
View 4 Excerpts
Highly Influenced

A clinical trial

L Kober, C Torp-Pedersen, JE Carlsen
Clin Exp Pharmacol Physiol, • 1995
View 5 Excerpts
Highly Influenced

Effect of Valsartan on hospitalization: results from Val-HeFT.

Journal of cardiac failure • 2003
View 1 Excerpt
Highly Influenced

Val-HeFT Investigators (Valsartan Heart Failure Trial)

AP Maggioni, I Anand, SO Gottlieb
J Am Coll Cardiol, • 2002
View 1 Excerpt
Highly Influenced

Similar Papers

Loading similar papers…